Jan‐Willem C. Alffenaar

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study

Keertan Dheda, Martin Enwerem, Rodolfo Romero Leyet et al. · European Respiratory Journal · 2017 · 294 citations · Full text

Pulmonary Tuberculosis, Health Sciences, Bedaquiline-containing Regimens +13

Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January–April 2020

Giovanni Battista Migliori, Pei Min Thong, Onno W. Akkerman et al. · Emerging infectious diseases · 2020 · 216 citations · Full text

Bedaquiline Resistance: Its Emergence, Mechanism, and Prevention

Thi Van Anh Nguyen, Richard Anthony, Anne‐Laure Bañuls et al. · Clinical Infectious Diseases · 2017 · 187 citations

New Drug, Medicinal Chemistry, Medicine +12

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

Edvardas Danila, Andrei Maryandyshev, Margareth Pretti Dalcolmo et al. · European Respiratory Journal · 2019 · 168 citations · Full text

Voriconazole metabolism is influenced by severe inflammation: a prospective study

Anette Veringa, Mendy ter Avest, Lambert F. R. Span et al. · Journal of Antimicrobial Chemotherapy · 2016 · 149 citations · Full text